EDANS
CAS No. 50402-56-7
EDANS( EDANS acid [5-((2-Aminoethyl)amino)napht | 1,5-EDANS )
Catalog No. M24462 CAS No. 50402-56-7
EDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 50MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEDANS
-
NoteResearch use only, not for human use.
-
Brief DescriptionEDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).
-
DescriptionEDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).
-
In Vitro——
-
In Vivo——
-
SynonymsEDANS acid [5-((2-Aminoethyl)amino)napht | 1,5-EDANS
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number50402-56-7
-
Formula Weight266.32
-
Molecular FormulaC12H14N2O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:13.89 mg/mL (52.16 mM; Need ultrasonic)
-
SMILESNCCNc1c(cccc2S(O)(=O)=O)c2ccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.E D Matayoshi, et al. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 1990 Feb 23;247(4945):954-8.
molnova catalog
related products
-
TASIN-1 Hydrochlorid...
TASIN-1 Hydrochloride is a selective inhibitor of truncated APC that acts by selectively killing colorectal cancer cells that express truncated APC by reducing cellular cholesterol levels and inducing apoptotic cell death through the ER stress/ROS/JNK signaling in colon cancer cells.
-
AZ-Dyrk1B-33
AZ-Dyrk1B-33 is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.
-
RC-3095
RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.
Cart
sales@molnova.com